ZEUS System vs Zio AT ECG Monitoring System
AI Verdict
Choose ZEUS System if…
Choose ZEUS System if your primary need is a robust, cloud-based AI software for advanced analysis of ECG data collected from compatible Zio wearable biosensors. This tool is ideal for healthcare providers who require sophisticated arrhythmia detection and characterization, and who benefit from preliminary report generation and HL7-based EHR integration for their existing Zio monitoring workflows.
View ZEUS System →Choose Zio AT ECG Monitoring System if…
Choose Zio AT ECG Monitoring System if you require a comprehensive mobile cardiac telemetry (MCT) service, including a dedicated wearable patch and wireless gateway for real-time data transmission. This system is best suited for clinicians needing continuous, uninterrupted ECG recording for up to 14 days with the capability for real-time insights and comprehensive end-of-wear reports, particularly for managing symptomatic and asymptomatic cardiac events where timely data access is crucial.
View Zio AT ECG Monitoring System →When choosing between the ZEUS System and the Zio AT ECG Monitoring System, physicians should consider their primary need for data acquisition and real-time monitoring capabilities. Both are offerings from iRhythm Technologies, are HIPAA compliant, and utilize AI for arrhythmia detection, particularly Atrial Fibrillation. The ZEUS System is specifically the AI-powered software component, designed to analyze ECG data from various wearable biosensors, including the Zio Watch and Zio monitors. It excels at cloud-based data analytics and preliminary report generation, making it suitable for practices focused on leveraging AI for interpreting existing ECG data streams.
The key practical difference lies in the comprehensive service offered by the Zio AT ECG Monitoring System. While it incorporates the ZEUS System’s AI algorithm, Zio AT is a complete mobile cardiac telemetry (MCT) service. This includes the wearable Zio AT patch for continuous recording, a wireless gateway for real-time data transmission, and a clinician portal for patient management and report interpretation. Therefore, Zio AT is best for physicians requiring a fully integrated solution that encompasses both the hardware for continuous, real-time data capture and the AI-driven analysis. Physicians who already have a preferred ECG data acquisition method or are looking for a software-only solution to enhance their analysis capabilities might lean towards the ZEUS System, while those seeking an end-to-end, real-time cardiac monitoring service should opt for the Zio AT system.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | ZEUS System | Zio AT ECG Monitoring System |
|---|---|---|
| Pricing | Not disclosed | Contact for pricing |
| Deployment | Cloud-based (AWS EC2 platform), no on-premise hardware. | Cloud-based (data analytics and clinician portal) |
| FDA Status | 1 AI-estimated | 1 AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Zio AT ECG Monitoring SystemTool B, the Zio AT ECG Monitoring System, offers a more comprehensive user experience with dedicated ZioSuiteu00ae clinician and MyZiou00ae patient mobile apps. These apps facilitate patient management, report interpretation, symptom logging, and education, providing a more complete and user-friendly ecosystem for all stakeholders compared to Tool A's general cloud-based analytics and report generation.
Clinical Value
TieBoth tools leverage the same core 'FDA-cleared deep-learned AI algorithm (ZEUS System)' for arrhythmia detection. They both provide continuous ECG monitoring for up to 14 days and support the detection of symptomatic and asymptomatic cardiac events. Given that Tool B explicitly states it uses Tool A's AI, their fundamental clinical capabilities and value are essentially identical.
Pricing & Value
TieNeither the ZEUS System (Tool A) nor the Zio AT ECG Monitoring System (Tool B) disclose their pricing publicly in the provided structured facts or through general web searches. Both require contacting the company for pricing details, making a direct comparison on this dimension impossible.
Enterprise Readiness
Zio AT ECG Monitoring SystemWhile both are FDA-cleared, HIPAA-compliant, have BAAs, and are cloud-based, Tool B (Zio AT ECG Monitoring System) demonstrates stronger documented enterprise readiness. Web searches confirm that the iRhythm monitoring service, which includes Zio AT, offers seamless EHR integration, including specific mentions of compatibility with major EHR systems like Epic via the Aura network. Tool A's mention of 'HL7-based EHR integration' is less specific than the comprehensive integration details available for Tool B.
Innovation
TieBoth tools are products of iRhythm Technologies and share the same foundational innovation: the AI-powered ZEUS System for arrhythmia detection. Tool A *is* the AI software, and Tool B *incorporates* this FDA-cleared deep-learned AI algorithm into its wearable monitoring service. Therefore, the core innovative technology is common to both, resulting in a tie.
Support & Docs
TieAs both tools are from iRhythm Technologies, they benefit from the same corporate support infrastructure. Web searches indicate that iRhythm provides extensive support resources, including FAQs, patient and provider support lines, and detailed Clinical Reference Manuals and Instructions for Use for its Zio products, including Zio AT and the ZEUS System itself. This suggests comparable levels of support and documentation for both offerings.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | ZEUS System | Zio AT ECG Monitoring System |
|---|---|---|
| Product Name | ZEUS System | Zio AT ECG Monitoring System |
| Company | iRhythm Technologies | iRhythm Technologies, Inc. |
| Core Function | AI-powered software for analyzing ECG data from wearable biosensors for long-term continuous cardiac monitoring, aiding in arrhythmia detection and characterization. | FDA-cleared, wearable mobile cardiac telemetry (MCT) service offering continuous, AI-powered ECG monitoring for long-term arrhythmia detection and comprehensive reporting. |
| Supported Medical Specialties | Cardiology, Family Medicine, Internal Medicine | Cardiology |
| Maximum Continuous Monitoring Duration | Up to 14 days | Up to 14 days |
| EHR Integration | HL7-based EHR integration | Not specified |
| Patient/Clinician Access Tools | Not specified | ZioSuiteu00ae clinician portal and mobile app, MyZiou00ae patient mobile app |
| AI Algorithm Used | AI-powered arrhythmia detection | FDA-cleared deep-learned AI algorithm (ZEUS System) for arrhythmia detection |
Videos
Demos, reviews, and walkthroughs featuring ZEUS System and Zio AT ECG Monitoring System.
Frequently Asked Questions
More Comparisons
More matchups featuring ZEUS System or Zio AT ECG Monitoring System
Backers
Who funded each tool's parent company.